Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4015 results

Sort By:

The Cardiovascular-Renal-Metabolic (CRM) Syndrome Survey in Jordan

Study ID: NCT06413160
Start Date: 2026-07-01
End Date: 2027-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10000

Intervention / Treatment
Sponsor

Jordan Collaborating Cardiology Group

Source: clinicaltrials.gov

Share:
Add to list

Atlas of Ultrasound Imaging of the Oral Cavity: Characterization and Description of Anatomical Structures

Study ID: NCT07463534
Start Date: 2026-04
End Date: 2027-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

University Hospital, Tours

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

Study ID: NCT07421297
Start Date: 2026-04-01
End Date: 2028-01-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

760

Intervention / Treatment

SYH2053injection

SYH2053 injection placebo

Sponsor

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies

Study ID: NCT07471334
Start Date: 2026-07-01
End Date: 2028-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

Psychiatric assessment

Sponsor

Central Hospital, Nancy, France

Source: clinicaltrials.gov

Share:
Add to list

Outcomes of Health Care Transition for AYA With a Cancer Predisposition

Study ID: NCT07456904
Start Date: 2026-06
End Date: 2037-11
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

56

Intervention / Treatment

Readiness Assessment

Transition Outcomes Survey A

Transition Outcomes Survey B

Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination

Study ID: NCT07410052
Start Date: 2026-04-15
End Date: 2027-08-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

28

Intervention / Treatment

Experimental 1

Experimental 2

Sponsor

Center for Health Sciences, Serbia

Source: clinicaltrials.gov

Share:
Add to list

Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.

Study ID: NCT07429643
Start Date: 2026-04-15
End Date: 2028-12-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

20

Intervention / Treatment

endoscopic ultrasonograhy guided chemptherapy injection

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Study ID: NCT07488676
Start Date: 2026-03-31
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

ASP546C

Sponsor

Astellas Pharma Global Development, Inc.

Source: clinicaltrials.gov

Share:
Add to list

The Effect of Acupuncture on Pulmonary Function Recovery Following Lung Resection

Study ID: NCT07443540
Start Date: 2026-04-01
End Date: 2027-01-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

56

Intervention / Treatment

Acupuncture Therapy

Incentive Spirometry (Standard Rehabilitation)

Sponsor

Chung Shan Medical University

Source: clinicaltrials.gov

Share:
Add to list

Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans

Study ID: NCT07104318
Start Date: 2026-04-01
End Date: 2030-03-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

360

Intervention / Treatment

Bismuth quadruple therapy with optimized PPI

Bismuth quadruple therapy with standard PPI

Clarithromycin triple therapy with optimized PPI

Clarithromycin triple therapy with standard PPI

Standard bismuth quadruple therapy

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list